Ad is loading...
AMLX
Price
$5.19
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
124 days until earnings call
ATRA
Price
$10.61
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

AMLX vs ATRA

Header iconAMLX vs ATRA Comparison
Open Charts AMLX vs ATRABanner chart's image
Amylyx Pharmaceuticals
Price$5.19
Change-$0.00 (-0.00%)
Volume$1.89M
CapitalizationN/A
Atara Biotherapeutics
Price$10.61
Change-$0.00 (-0.00%)
Volume$81.18K
CapitalizationN/A
AMLX vs ATRA Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AMLX vs. ATRA commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and ATRA is a Buy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (AMLX: $5.19 vs. ATRA: $10.61)
Brand notoriety: AMLX and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 114% vs. ATRA: 70%
Market capitalization -- AMLX: $361.25M vs. ATRA: $61.11M
AMLX [@Biotechnology] is valued at $361.25M. ATRA’s [@Biotechnology] market capitalization is $61.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while ATRA’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 5 bearish.
  • ATRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +3.39% price change this week, while ATRA (@Biotechnology) price change was -16.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

AMLX is expected to report earnings on Mar 26, 2025.

ATRA is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($361M) has a higher market cap than ATRA($66.1M). ATRA YTD gains are higher at: -17.239 vs. AMLX (-64.742). ATRA has higher annual earnings (EBITDA): -123.21M vs. AMLX (-212.04M). AMLX has more cash in the bank: 234M vs. ATRA (67.2M). AMLX has less debt than ATRA: AMLX (2.57M) vs ATRA (49.9M). AMLX has higher revenues than ATRA: AMLX (196M) vs ATRA (100M).
AMLXATRAAMLX / ATRA
Capitalization361M66.1M546%
EBITDA-212.04M-123.21M172%
Gain YTD-64.742-17.239376%
P/E Ratio2.69N/A-
Revenue196M100M196%
Total Cash234M67.2M348%
Total Debt2.57M49.9M5%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATRA
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ATRA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JATTX29.480.46
+1.59%
Janus Henderson Triton T
HLRRX11.780.09
+0.77%
LDR Real Estate Value Opportunity Instl
SPGIX49.300.26
+0.53%
SEI Large Cap Growth I (SIMT)
SIFAX8.020.02
+0.25%
SEI Multi-Asset Inflation Mgd F (SIMT)
APDHX21.40-0.02
-0.09%
Artisan Global Equity Advisor

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-0.66%
IKNA - ATRA
72%
Closely correlated
+1.76%
AMLX - ATRA
55%
Loosely correlated
-0.76%
ABCZF - ATRA
53%
Loosely correlated
N/A
ADMA - ATRA
44%
Loosely correlated
-0.33%
RAPT - ATRA
37%
Loosely correlated
-1.87%
More